NRXSMICRO

NeurAxis, Inc.

HealthcareBiotechnology
$8.81
$0.00(+1.38%)
52W$1.94
$9.33
Updated May 7, 12:00 AM
RSI68
RS Rating96/99
Beta1.43
Volatility111%
F-Score1/9
Mkt Cap$94M
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

NeurAxis, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 96), indicating clear outperformance against the broad market. Earnings growth of 33% provides fundamental context to the price action. However, price is extended 25% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
96
out of 99
Market Leader
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
1.43
vs S&P 500
ABOVE MKT
52W Position
93%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$7.03
50 SMA > 100 SMA$5.69
100 SMA > 150 SMA$4.75
150 SMA > 200 SMA$4.20

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$7.57+16.34%ABOVE
50 SMA$7.03+25.32%ABOVE
100 SMA$5.69+54.82%ABOVE
150 SMA$4.75+85.52%ABOVE
200 SMA$4.20+109.70%ABOVE

Price Performance

1D+1.4%
1W+18.4%
1M+21.5%
3M+102.5%
6M+248.2%
YTD+97.5%
1Y+302.3%
3Y+13.7%
52-Week Trading Range93% from low
$8.81
52W Low$1.94
52W High$9.33

Technical Indicators

RSI (14)BULLISH
67.5
305070
VCP ScoreCOOL
3/10
Base depth: 56.4%

Risk Profile

Beta
1.43
52W Vol
111%
ATR
$0.59
Max DD (1Y)
-43%

Volume Analysis

Today
301.9K
50D Avg
199.9K
Vol Ratio
1.51x
Liquidity
ILLIQUID

Earnings Momentum

Q1'25-3%
$-0.33
Q2'25+48%
$-0.22
Q3'25+4%
$-0.24
Q4'25+33%
$-0.16
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:+13.08%
3 Years:+9.96%
TTM:+32.89%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+22.76%

Stock Price CAGR

10 Years:+3.92%
5 Years:+7.99%
3 Years:+13.66%
1 Year:+302.28%

Return on Equity

10Y Avg:-933.2%
5Y Avg:-1168.7%
3Y Avg:-1382.9%
Last Year:-306.0%

Key Metrics

Market Cap$94M
Gross Margin84.2%
Net Margin-2.2%
Piotroski F-Score1/9

Frequently Asked Questions

Is NRXS in an uptrend right now?

NRXS has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, NRXS is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is NRXS overbought or oversold?

NRXS's RSI (14) is 68. The stock is in neutral territory, neither overbought nor oversold.

Is NRXS outperforming the market?

NRXS has a Relative Strength (RS) Rating of 96 out of 99. Yes, NRXS is a market leader, outperforming 96% of all stocks over the past 12 months.

Where is NRXS in its 52-week range?

NRXS is trading at $8.81, which is 94% of its 52-week high ($9.33) and 93% above its 52-week low ($1.94).

How volatile is NRXS?

NRXS has a Beta of 1.43 and 52-week volatility of 111%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.